BR112013004458A2 - método e kit para detectar a presença de células que expressam he-4 em um indivíduo humano, e, método para o monitoramento de eficácia de tratamento de um paciente de câncer humano - Google Patents

método e kit para detectar a presença de células que expressam he-4 em um indivíduo humano, e, método para o monitoramento de eficácia de tratamento de um paciente de câncer humano

Info

Publication number
BR112013004458A2
BR112013004458A2 BR112013004458A BR112013004458A BR112013004458A2 BR 112013004458 A2 BR112013004458 A2 BR 112013004458A2 BR 112013004458 A BR112013004458 A BR 112013004458A BR 112013004458 A BR112013004458 A BR 112013004458A BR 112013004458 A2 BR112013004458 A2 BR 112013004458A2
Authority
BR
Brazil
Prior art keywords
kit
monitoring
detecting
expressing cells
cancer patient
Prior art date
Application number
BR112013004458A
Other languages
English (en)
Portuguese (pt)
Inventor
Elizabeth Swisher
Ingegerd Hellstrom
Jade Jaffar
Karl Erik Hellstrom
Pu Liu
Original Assignee
Univ Washington Ct Commerciali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington Ct Commerciali filed Critical Univ Washington Ct Commerciali
Publication of BR112013004458A2 publication Critical patent/BR112013004458A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013004458A 2010-08-26 2011-08-26 método e kit para detectar a presença de células que expressam he-4 em um indivíduo humano, e, método para o monitoramento de eficácia de tratamento de um paciente de câncer humano BR112013004458A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37738710P 2010-08-26 2010-08-26
PCT/US2011/049274 WO2012027631A2 (en) 2010-08-26 2011-08-26 Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells

Publications (1)

Publication Number Publication Date
BR112013004458A2 true BR112013004458A2 (pt) 2016-06-07

Family

ID=45724080

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013004458A BR112013004458A2 (pt) 2010-08-26 2011-08-26 método e kit para detectar a presença de células que expressam he-4 em um indivíduo humano, e, método para o monitoramento de eficácia de tratamento de um paciente de câncer humano

Country Status (10)

Country Link
US (2) US20130224772A1 (enExample)
EP (1) EP2609429B1 (enExample)
JP (1) JP6097688B2 (enExample)
CN (1) CN103180732B (enExample)
AU (1) AU2011293217A1 (enExample)
BR (1) BR112013004458A2 (enExample)
CA (1) CA2809368C (enExample)
MX (1) MX2013002268A (enExample)
RU (1) RU2600891C2 (enExample)
WO (1) WO2012027631A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
JP5887364B2 (ja) 2011-02-17 2016-03-16 フジレビオ ダイアグノスティックス インコーポレイテッド ＨＥ４ａの測定のための組成物および使用方法
CN103424551B (zh) * 2013-08-06 2015-08-26 江苏福隆生物技术有限公司 人附睾上皮分泌蛋白4定量测定试剂盒及其检测方法
US10267802B2 (en) * 2015-09-23 2019-04-23 The Board Of Trustees Of The Leland Stanford Junior University Methods of prognosis and diagnosis of ovarian cancer
EP3391053B1 (en) * 2015-12-17 2020-02-26 Roche Diagnostics GmbH Methods of detecting a relapse of a lung adenocarcinoma based on marker human epididymis protein 4 (he 4) and related uses
CN109280084B (zh) * 2018-03-09 2022-04-29 河南大学 一种胶体硒标记的抗he4抗体、试剂盒及其制备方法
CN109480771B (zh) * 2018-10-17 2021-09-07 江西惠肽生物科技有限公司 一种卵巢肿块良恶的确定方法及确定装置
CN110895279B (zh) * 2019-11-27 2023-02-28 普健生物（武汉）科技有限公司 一种检测人附睾分泌蛋白4的化学发光试剂盒
WO2022204017A1 (en) * 2021-03-22 2022-09-29 Curative Inc. Immunization assessments using saliva or nasal specimen
CN113045663B (zh) * 2021-04-18 2022-04-01 深圳市国创纳米抗体技术有限公司 一种抗he4的纳米抗体1a8及其应用
CN117487018B (zh) * 2023-09-27 2024-05-17 武汉爱博泰克生物科技有限公司 抗人附睾分泌蛋白4的兔单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017342A (en) * 1988-06-01 1991-05-21 Ortho Diagnostic Systems Inc. Device for immunoassay determinations
WO2002046765A2 (en) * 2000-11-08 2002-06-13 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
ES2363757T3 (es) * 2005-09-15 2011-08-16 Val-Chum, S.E.C. Procedimientos de diagnóstico del cáncer de ovarios.
CN101473041B (zh) * 2006-01-04 2017-11-14 富士瑞必欧美国公司 He4与其它生化标记物在评估子宫内膜癌和子宫癌中的应用
WO2008032084A1 (en) * 2006-09-13 2008-03-20 Oncimmune Ltd Improved immunoassay methods
AU2008226587A1 (en) * 2007-03-09 2008-09-18 Tripath Imaging, Inc. HE4 monoclonal antibodies and methods for their use
JP5144742B2 (ja) * 2007-03-29 2013-02-13 フジレビオ ダイアグノスティックス インコーポレイテッド 乳がんの評価のためのｈｅ４の使用
WO2010061393A1 (en) * 2008-11-30 2010-06-03 Compugen Ltd. He4 variant nucleotide and amino acid sequences, and methods of use thereof
CN101525614A (zh) * 2009-04-13 2009-09-09 大连美亿德生物科技有限公司 人卵巢癌肿瘤标志物he4酶联免疫诊断试剂盒

Also Published As

Publication number Publication date
RU2013113314A (ru) 2014-10-10
EP2609429A4 (en) 2014-03-19
RU2600891C2 (ru) 2016-10-27
MX2013002268A (es) 2014-02-03
CN103180732B (zh) 2017-09-08
EP2609429A2 (en) 2013-07-03
JP2013536442A (ja) 2013-09-19
US20180217158A1 (en) 2018-08-02
US20130224772A1 (en) 2013-08-29
JP6097688B2 (ja) 2017-03-15
AU2011293217A1 (en) 2013-04-11
CA2809368A1 (en) 2012-03-01
WO2012027631A2 (en) 2012-03-01
EP2609429B1 (en) 2017-09-20
CA2809368C (en) 2021-08-24
CN103180732A (zh) 2013-06-26
WO2012027631A3 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
BR112013004458A2 (pt) método e kit para detectar a presença de células que expressam he-4 em um indivíduo humano, e, método para o monitoramento de eficácia de tratamento de um paciente de câncer humano
BR112013000745A2 (pt) "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo"
IL254062B (en) Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
BR112012031117A2 (pt) método para tratamento antienvelhecimento de pele e kit para tratamento antienvelhecimento de pele
BR112012018943A8 (pt) medicamento e método para o tratamento e/ou prevenção de um câncer
ZA201402948B (en) Mobile treatment, diagnostic and minor surgery facility
IL226049A0 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
PL2870913T3 (pl) Urządzenie do pobierania, przechowywania i/albo obróbki krwi lub innych substancji pochodzenia ludzkiego lub zwierzęcego, i do stosowania preparatów krwiopochodnych lub innych preparatów biologicznych
PL2619576T3 (pl) Środki i sposoby do prognozowania odpowiedzi na leczenie u pacjenta chorego na nowotwór złośliwy
IL227301B (en) Methods and devices for treating skin or wounds
BRPI0919690A2 (pt) métodos para detectar células-tronco de tumor em um paciente, para monitorar o efeito do tratamento de um tumor em um paciente, e para radioterapia em um paciente com câncer, formulaçõ farmacêutica, e, composto
EP2568901A4 (en) ULTRASONIC TREATMENT AND SURVEILLANCE FACILITATED BY REFLECTION
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
EP2493483A4 (en) TOPICAL SKIN TREATMENT FORMULATION FOR ROSACEA AND CORRESPONDING METHOD
EP2637625A4 (en) METHOD AND DEVICE FOR TREATING SOFT TISSUE
BRPI0917189A2 (pt) dispositivo para uso em tratamento cirúrgico de tórax em funil e método de tratamento.
IL236516A0 (en) Methods and compositions for diagnosis and treatment of cancer
EP2612592A4 (en) DEVICE AND METHOD FOR DISPLAYING MEDICAL TREATMENT INFORMATION AND PROGRAM THEREFOR
IL221459A0 (en) A method and composition for skin care comprising cord blood serum or plasma or components thereof
LT2633077T (lt) Analitiniai būdai ir gardelės, skirti panaudoti agentų, sukeliančių žmogaus odos jautrinimą, identifikavimui
ZA201307641B (en) Human tissue factor antibody and uses thereof
GB201305198D0 (en) Kits, components and methods for tissue reconstruction
EP2875158A4 (en) USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN
IL238066A0 (en) Method and system for treating biological tissue

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.